Automated, High Purity Cell Isolation for Efficient Cell Therapy Manufacturing

In cell therapy applications, commonly employed cell purification platforms for large-scale isolation of immune or stem cells separate cells based on a single cell surface antigen. Enrichment based on multiple cell surface markers or different expression levels of these markers often requires the use of a traditional cell sorter. This webinar describes the CGX10 Cell Isolation System from Sony Biotechnology, a fully closed, automated system suitable for clinical grade, GMP-compliant cell sorting. The system utilizes a novel microfluidics technology to achieve high purity cell isolation within a closed and sterile microfluidics chip.

In this webinar, we will deliver a virtual demo of the CGX10 system’s capabilities, including advanced automation, innovative software with an intuitive user interface, built-in 21 CFR Part 11 compliance features, and purpose-built consumable installation. We will also discuss the CGX10’s role in advancing next-gen cell therapies such as CAR-T, CAR-Treg, and stem cell based therapies.

Who Should Attend;

This webinar will be of interest to cell therapy specialists, clinical scientists, and production engineers working in cell and gene therapy manufacturing at the research, process development, or GMP production stage. Professionals involved in developing workflows for wide range of cell therapy modalities, including CAR-T, Treg, TIL-based, CAR-NK and other immune cell therapies, and stem cell–based therapies, would benefit from this webinar.

Learning Objectives;

• Take a closer look at the CGX10’s key benefits, features, and practical applications
• Explore the innovative software navigation wizard, featuring dedicated user roles and advanced sorting modes to enable a seamless transition into cell therapy manufacturing
• Review software capabilities in compliance with 21 CFR Part 11 guidelines, supporting secure, traceable, and reliable electronic records
• Understand the use of the CGX10 for sorting ultra-rare, multimarker subsets across a wide range of applications, including CAR-T therapies for hematological cancers, CAR-Treg therapies for autoimmune diseases, and iPSC-derived and stem cell therapies for oncology and regenerative medicine